Selective serotonin reuptake inhibitors for stroke recovery: A systematic review and meta-analysis

Stroke

Volumn 44, Issue 3, 2013, Pages 844-850

  Mead, Gillian E ^a   Hsieh, Cheng Fang ^b   Lee, Rebecca ^c   Kutlubaev, Mansur ^d   Claxton, Anne ^e   Hankey, Graeme J ^e   Hackett, Maree ^f  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NHS FIFE   (United Kingdom)

^d Kuvatov Republic Clinical Hospital   (Russian Federation)

^e ROYAL PERTH HOSPITAL   (Australia)

^f GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

Antidepressants; Meta analysis; Recovery; Selective serotonin reuptake inhibitors; Stroke

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY; BLEEDING; CEREBROVASCULAR ACCIDENT; COGNITION; DEPRESSION; GASTROINTESTINAL SYMPTOM; HUMAN; META ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

AGED; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; STROKE; TREATMENT OUTCOME;

EID: 84876282903     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.673947     Document Type: Review

References (64)

1. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182-187.
2. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123-130.
3. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol. 2007;18:391-418.
4. Shin TK, Kang MS, Lee HY, Seo MS, Kim SG, Kim CD, et al. Fluoxetine and sertraline attenuate postischemic brain injury in mice. Korean J Physiol Pharmacol. 2009;13:257-263.
5. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. London, UK: The Cochrane Collaboration; 2011.
6. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011.
7. Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351-359.
8. Brown KW, Sloan RL, Pentland B. Fluoxetine as a treatment for poststroke emotionalism. Acta Psychiatr Scand. 1998;98:455-458.
9. Chen WY, Liu FY, Yang AP. Study of effect of integrative Chinese herbs with fluoxetine on rehabilitation of neurological impairment in patients with post-stroke depression. Chengdu U J Tradi Chin Med. 2001;24:20-23.
10. Cheng F, Shao G, Bao S. Study of effect on neurologic function rehabilitation in patient with post-stroke depression. Chin J Clin Rehabil. 2003;7:108-109.
11. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211-1214.
12. Feng BL, Wang QC, Li ZY. Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction. Zhong Xi Yi Jie He Xue Bao. 2004;2:182-184.
13. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250:347-351.
14. He P. Randomized controlled observation on the effect of early application of fluoxetine in preventing depression after stroke. Chin J Clin Rehabil. 2004;8:6016-6017.
15. Hu Y, Suo A, Xiang L. The comparative study of the effectiveness of fluoxetine on the stroke patients with depressive symptoms. Shanghai Arch Psychiatry. 2002;14:149-150.
16. Huang X-H. The clinical correlation study and the effect of fluoxetine intervention on poststroke depression. Chin J Clin Rehabil. 2002;6:2296-2297.
17. Ji Q, Xie L. Efficacy of fluoxetine in the treatment of 20 patients with depression after stroke. Herald Med. 2000;19:329.
18. Kong Y. Fluoxetine for poststroke depression: A randomized placebo controlled clinical trial. Neural Regeneration Res. 2007;2:162-165.
19. Li F, Gu DX, Ceng SH, Xu JW. Effect of paroxetine on prognosis of patients with post cerebral infarction depression. Chin J New Drugs Clin Remedies. 2002;21:11-13.
20. Li J, He Q-Y, Han M-F. Recent effect of fluoxetine in improving neurologic impairment and preventing post-stroke depression in the early stage. Chin J Clin Rehabil. 2004;8:1208-1209.
21. Li C-M, Jiang X-D, Liao G, Lei J-M, Lan S, Ni F-W. Effect of antidepressant drugs in early period on the recovery of post-stroke depression. Chin J Clin Rehabil. 2004;8:3713-3715.
22. Li LT, Wang SH, Ge HY, Chen J, Yue SW, Yu M. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression. J Altern Complement Med. 2008;14:841-846.
23. Liang Z, Shuliang T. Clinical efficacy of fluoxetine in treatment of patients with depression after acute stroke. Chin J Clin Rehabil. 2003;7:1924-1925.
24. Liu L-X. Recent effect of drug intervention on post-stroke anxiety. Chin J Clin Rehabil. 2004;8:6600-6601.
25. Song J-G. Effects of fluoxetine hydrochloride on depressive symptoms and P300 after cerebral stroke. Chin J Clin Rehabil. 2006;10:160-162.
26. Wang X, Tan Z, Wu Z, Gao J, Feng M. The effects of anti-depression therapy on post-stroke depression and neurologic rehabilitation in the elderly patients. Chin J Geriatrics. 2003;22:270-273.
27. Wen Z-X. The influence of post-stroke prophylactic anti-depression treatment on nerve functional rehabilitation. Acta Academiae Medicinae Qingdao Universitatis. 2006;42:253-254.
28. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829-1832.
29. Xu J, Tan J, Ou L. A study on treatment of fluoxetine for depression in early recovery stage of cerebral infarction. Chinese Journal of Rehabilitation Medicine 2001;16:281-283.
30. Xu B, Zhou WY, Zhang SJ. Observation on effect of Wuling Capsule in treating poststroke depression. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27:640-642.
31. Zhou B. Effects of fluoxetine on neurofunctional recovery of nondepressed patients after stroke. Chin J Clin Rehabil. 2003;7:374-375.
32. Zhou Z-l, Liang L-z, Yan Y-x. Preventative effects of fluoxetine on poststroke depression. Chin JMAP. 2008;25:263-264.
33. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry. 2006;67:1104-1109.
34. Burns A, Russell E, Stratton-Powell H, Tyrell P, O'Neill P, Baldwin R. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry. 1999;14:681-685.
35. Finkenzeller W, Zobel I, Rietz S, Schramm E, Berger M. Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness. Nervenarzt. 2009;80:805-812.
36. Guo RY, Su L, Liu LA, Wang CX. Effects of Linggui Bafa on the therapeutic effect and quality of life in patients of post-stroke depression. Zhongguo Zhen Jiu. 2009;29:785-790.
37. Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66:708-716.
38. Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics. 2003;44:216-221.
39. Xie R, Liu J, Quan H. A prospective random clinical contrast study of treatment with sertraline in elderly patients with post-stroke depression. Chin J Clin Neurosci. 2005;13:294-297.
40. Chen W, Wang G-F, Chen X-H, Sheng Y-L, Zhu H. Effects of paroxetine on function recovery in patients with post-stroke depression. Chin J Clin Rehabil. 2002;6:2014-2015.
41. Chen T, Li J, Han M. A study on paroxetine in the treatment for poststroke depression. Jiangxi Med. 2005;40:382-384.
42. GlaxoSmithKline. An 8-week double-blind placebo controlled parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from depression following stroke. GSK Clinical Study Register. Available at: http://gsk-clinicalstudyregister.com/result-detail.jsp?protoc olId=29060%2f625&studyId=FBD21B0A-3941-4A26-B814-793B2BA 5697E&compound=paroxetine. Accessed September 7, 2011.
43. He Y, Wang X, Xiao C. Prospective study of effects of paroxetine with mental intervention on depression and anxiety after stroke. Nerv Dis Ment Health. 2005;5:6-13.
44. Lai J. The effect of using paroxetine to treat post stroke depression. J Guangdong Med Coll. 2006;24:585-586.
45. Li Y, Wang X, Qian FS. Related factors of post-stroke depression and effect of paroxetine. Shandong Arch Psychiatry. 2005;18:209-210.
46. Xu J, Wang J, Liu, J. Preventative effects of antidepressants on poststroke depression. Chin Mental Health J. 2006;20:186-188.
47. Yang J, Zhao Y, Bai S Controlled study on antidepressant treatment of patients with post-stroke depression. Chin Mental Health J. 2002;16:871-872.
48. Yang J. Therapeutic effect of paroxetine on patients with early poststroke depression and the serum interleukins. Chin J Cerebrovascular Dis. 2011;8:235-238.
49. Ye L-X, Wang H, Wang Y-D, Zhong L, Liang D-S, Guo Y. Effect of antidepressive therapy on the rehabilitation of psychological and neurological function after stroke. Chin J Clin Rehabil. 2004;8:6826-6828.
50. Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol. 2009;256:1152-1158.
51. Anderson G, Verstergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke.1994;25:1099-104.
52. Li W-Q, Li D-X. The efficacy of citalopram for post-stroke depression and its effects on stroke rehabilitation. Int J Cerebrovascular Dis. 2006;14:275-278.
53. Liu Y. Effect of citalopram treatment on post-stroke depression and neurological functional rehabilitation. Chin J Rehabil. 2006;21:174-175.
54. Miao S-Y, Shi Y-J. Related factors of post-stroke depression and therapeutical effect of citalopram. Chin J Clin Rehabil. 2004;8:3718-3719.
55. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA. 2008;299:2391-2400.
56. Jia W. Effect of early intervention on recovery of motor function and recurrent stroke in patients with post-stroke depression. Chin J Clin Rehabil. 2005;9:4-5.
57. Yi ZM, Liu F, Zhai SD. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis. Int J Clin Pract. 2010;64:1310-1317.
58. Bhogal SK, Teasell R, Foley N, Speechley M. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc. 2005;53:1051-1057.
59. Chen Y, Guo JJ, Zhan S, Patel NC. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Ann Pharmacother. 2006;40:2115-2122.
60. Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol. 2007;22:159-166.
61. Berends HI, Nijlant JM, Movig KL, Van Putten MJ, Jannink MJ, Ijzerman MJ. The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review. Eur J Phys Rehabil Med. 2009;45:621-630.
62. van de Meent H, Geurts ACH, Van Limbek. Pharmacological treatment of post-stroke depression: a systematic review of the literature. Top Stroke.Rehabil 2003;10:79-92.
63. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008: CD003437.
64. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008:CD003689.